- Research works
- 36 ▼ 38% vs 2013–17
- Citations
- 1.2k 34.8 per fractional work
- Top-10% rate
- 12.5% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Ambrx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Ambrx (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Monoclonal Antibody, Breast Cancer and Chemotherapy.
- Tumor Targeting
- Human Rights
- Constitutional Law
- Bacterial Therapy
- DNA nanotechnology
- Self-Assembly
- Chimeric Antigen Receptor
- Biopharmaceuticals
- Angiogenesis
- Cancer Therapy
- Radioimmunotherapy
- Targeted Therapy
- Inflammation
- Tumor Regression
- Cancer
- Trastuzumab
- Chemotherapy
- Monoclonal Antibody
- Antibody Engineering
- Glycosylation
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Breast Cancer
- HER2
- Immunotherapy
- PET Imaging
- Lymphoma
- Cancer Treatment
- Gene Therapy
- Radiopharmaceuticals
- Cancer Immunotherapy
- Apoptosis
- CAR T Cells
- Immunogenicity
- Biosensors
- Extracellular Matrix
- Cell Death
- Genetic Mutations
- Mitochondria
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Monoclonal Antibodies7▲ 140×3 topics
- Glycosylation7▲ 84×3 topics
- Therapeutic Antibodies6▲ 142×2 topics
- Antibody Engineering6▲ 165×1 topic
- Fc Receptors6▲ 165×1 topic
- Monoclonal Antibody5▲ 189×2 topics
- Breast Cancer5▲ 46×2 topics
- Chemotherapy4▲ 17×2 topics
- HER24▲ 388×1 topic
- Trastuzumab4▲ 275×1 topic
- Immunotherapy4▲ 15×5 topics
- Cancer2▲ 5.0×10 topics
- PET Imaging2▲ 31×2 topics
- Tumor Regression2▲ 74×2 topics
- Lymphoma2▲ 37×2 topics
- Inflammation2▲ 2.3×8 topics
- Cancer Treatment2▲ 19×2 topics
- Targeted Therapy2▲ 23×2 topics
- Gene Therapy2▲ 18×4 topics
- Radioimmunotherapy2▲ 123×1 topic
- Radiopharmaceuticals2▲ 123×1 topic
- Cancer Therapy2▲ 7.0×3 topics
- Cancer Immunotherapy1▲ 27×2 topics
- Angiogenesis1▲ 9.1×4 topics
- Apoptosis1▲ 9.4×2 topics
- Biopharmaceuticals1▲ 52×2 topics
- CAR T Cells1▲ 84×1 topic
- Chimeric Antigen Receptor1▲ 84×1 topic
- Immunogenicity1▲ 70×2 topics
- Self-Assembly1▲ 9.1×2 topics
- Biosensors1▲ 5.9×1 topic
- DNA nanotechnology1▲ 33×1 topic
- Extracellular Matrix1▲ 12×2 topics
- Bacterial Therapy1▲ 64×1 topic
- Cell Death1▲ 14×2 topics
- Constitutional Law1▲ 21×1 topic
- Genetic Mutations1▲ 5.4×2 topics
- Human Rights1▲ 3.3×1 topic
- Mitochondria1▲ 17×2 topics
- Tumor Targeting1▲ 21×1 topic
Which research topics does Ambrx (United States) publish most on?
By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Brazilian Legal Issues.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 HER2/EGFR in Cancer Research Oncology 1 works
- 4 Brazilian Legal Issues Law 1 works
- 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Protein purification and stability Molecular Biology 0 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 9 Immune Cell Function and Interaction Immunology 0 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ambrx (United States)'s research output changed?
Output in 2018–2022 was 38% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in La Jolla
- Scripps Institution of Oceanography
- Salk Institute for Biological Studies
- Scripps Clinic
- Sanford Burnham Prebys Medical Discovery Institute
- National University
- Neurosciences Institute
- La Jolla Alcohol Research
- Behavioral Pharma (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.